This was a low-key week for the biotech sector before the onset of the first-quarter earnings season. Biotech giant Bristol Myers Squibb BMY was down on data from the schizophrenia study while ...

Rezolute advances HI drug trial after DMC review and secures $90 million in funding through stock offering to support ...

The claims cover combination treatment of onvansertib + bev for all bev-naïve patients including RAS-mutated and RAS wild type mCRC across all lines of therapy through 2043SAN DIEGO, April 23, 2025 ...

Vanda Pharmaceuticals is suing the FDA again, this time alleging the agency is unlawfully delaying a hearing to discuss the ...

Discover why BTK inhibitors have attracted interest for treating multiple sclerosis, as a few late-stage candidates close in ...

Paul Reider has followed Coherus BioSciences’ last biosimilar product out the door. | Paul Reider has followed Coherus ...

Oncology experts discuss de-escalation strategies that can reduce toxicity, save a billion in healthcare costs, and make lung ...

Steminent Biotherapeutics specializes in developing innovative stem cell-based therapeutics that offer new hope for patients ...

Q4 Results Today: As the Indian stock market continued its bullish run, Investors will observe the Q4 results announcements ...

VoPay, a leading provider of embedded financial technology, today announced the launch of its new Cross-Border Payments-as-a-Service solution. Built for software platforms and financial institutions, ...

PiLLRx launches today with the world's first anonymous, crowd-sourced community platform designed to fill a critical gap for people using prescription medications ? starting with GLP-1s. sPillRx ...

The biotech industry has been under pressure due to the global uncertainty caused by the tariff war. Though pharmaceuticals ...